Context: Extremely low hemoglobin (Hgb) values have been linked to increased fracture risk at different sites. However, careful assessment of clinically defined anemia and fracture risk is lacking.
hemoglobin values as associated with increased mortality, although the World Health Organization anemia definitions of Hgb ,12 g/dL in women and ,13 g/dL in men did not discriminate risk as well as a lower Hgb value did (5) .
Anemia has been shown to increase the risk for serious skeletal events as well. In the Women's Health Initiative, those with anemia had a 38% to 81% increased risk of incident fracture at any skeletal site (6) . Both high and low Hgb levels have been associated with increased risk for hip fracture, based on Medicare claims in older men and women (7) . We have shown that bone mineral density (BMD) loss is associated with anemia in the Osteoporotic Fractures in Men (MrOS) study (8) and others have established the relationship of anemia and reduced cortical bone density by peripheral quantitative computed tomography assessment near the time of blood sampling in a different prospective observational cohort (9) .
We sought to evaluate whether a low Hgb value would predict increased risk of fractures in a prospective observational cohort of elderly men. We were particularly interested in the distinction between spine and nonspine fractures because we have previously shown that bone loss at the hip but not the spine is associated with anemia. Bone loss was also associated with high neutrophil and low lymphocyte counts in our earlier study (8) , thus we also explored the possibility that counts of WBC subtypes and platelets may be related to increased risk of fracture.
Methods

Study population
The MrOS study is a prospective observational study of bone health evaluation and management in men. Communitydwelling older men were recruited from six sites across the United States (Birmingham, AL; Minneapolis, MN; Palo Alto, CA; Monongahela Valley near Pittsburgh, PA; Portland, OR; and San Diego, CA), as previously described (10, 11) . Eligible men were $65 years old, able to walk without assistance, and did not have bilateral hip replacement surgery. A total of 5994 men were enrolled from March 2000 to April 2002; of these, 4681 completed the third clinic visit between March 2007 and March 2009. A cohort of 3636 men had a complete blood cell count (CBC) performed, which included white blood cell (WBC) count and differential counts of WBC subtypes at visit 3. Four men with extreme total WBC values (i.e., .30,000 total WBC count) were excluded from all analyses. The remaining 3632 men composed the analytic study population.
Pertinent participant characteristics
Demographic information, medical history, and tobacco and alcohol use were ascertained for MrOS participants at baseline and follow-up visits, using standardized questionnaires and inperson participant interviews. Self-reported health was reported by lifestyle questionnaire. The Physical Activity Scale for the Elderly (PASE) questionnaire was administered to estimate physical activity (12) . At each visit, standing height (cm) was measured on Harpenden stadiometers and weight (kg) was measured on balance beams or digital scales. These values were used to calculate body mass index (BMI). Medications were brought in by participants and verified by study staff. All prescription and over-the-counter medications recorded by the clinics were stored in an electronic medications inventory database (San Francisco Coordinating Center, San Francisco, CA). Each medication was matched to its ingredient(s) based on the Iowa Drug Information Service Drug Vocabulary (College of Pharmacy, University of Iowa, Iowa City, IA) (13).
Bone mineral density
Total hip (TH) bone mineral density (BMD) was used because it was the site of strongest association with anemia in our prior work (8) . BMD was measured at baseline and visit 3, using dual-energy X-ray absorptiometry (DXA) on Hologic QDR
Complete blood cell counts
At visit 3, CBC counts and WBC subtypes were measured at local Quest Diagnostic laboratories for five study sites and Stanford Outreach for one site, using fasting blood samples. Measurements were standardized across laboratories and included Hgb concentration and counts of platelet, total WBCs, and WBC subtypes: neutrophils, lymphocytes, and monocytes. We defined anemia using a clinical definition of Hgb ,12 g/dL. Mean corpuscular volume was used to categorize anemia as microcytic (,81 fL), normocytic (81 to 99 fL), and macrocytic (.100 fL) for descriptive purposes. Exploratory analyses used definitions for thrombocytopenia (or low platelet count) as ,150,000/mL platelets, whereas WBC subtype counts were categorized by quintiles: "low" (first, or lowest, quintile), "middle" (middle: second through fourth quintiles), and "high" (highest quintile), based on their corresponding distributions in the entire analytic study population.
Fracture reporting and adjudication
Clinical fractures were reported by participants via triannual questionnaires or direct self-report. Reported fractures were followed up by study staff and adjudicated based on radiology reports or radiograph reading by coordinating center radiologists. Nonspine fracture sites included the hip, wrist, face, rib, chest, sternum, shoulder, arm, hand, pelvis, tailbone, ankle, foot, and heel. Spine fracture sites included thoracic and lumbar vertebrae. Pathologic fractures were excluded. Participants were followed from visit 3 to the date of first site-specific (i.e., spine or nonspine) adjudicated fracture, date of death, or the February 2016 fracture follow-up questionnaire, whichever came first. "Prevalent fracture" was defined as fracture at any site after age 50 years but before visit 3.
Statistical analyses
MrOS visit 3 was chosen as the study starting point because CBC counts were obtained at this interval. Participant characteristics evaluated at visit 3 included age, BMI, height, weight change (baseline to visit 3), prevalent fracture, cancer history (including nonmelanoma skin cancer), rheumatoid arthritis (RA) history, activity score (PASE), self-reported health, smoking status, alcohol intake, corticosteroid use, hydrochlorothiazide use, bone medication use, calcium, vitamin D use, TH BMD, and TH BMD change (calculated from baseline to visit 3 and converted to an annualized percentage).
We compared participant characteristics and BMD variables by anemia status and fracture status using analysis of variance F test for continuous variables and x 2 test for dichotomous variables. Participant characteristics for which P # 0.10 were considered possible confounders and controlled for in multivariate (MV) models.
Using any fracture, nonspine fracture, and spine fracture as events, we separately calculated the probability of being fracture free during follow-up depending on anemia status and plotted them according to the Kaplan-Meier method. Follow-up time was derived separately for spine fracture and nonspine fracture outcomes. The first spine, nonspine, skull, finger, or toe fracture event ended follow-up time for the "any fracture" outcome. We performed separate Cox proportional-hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for hazards of specific types of fractures (any fracture, spine fracture, and nonspine fracture) in men with anemia vs men without anemia.
Four sets of models were developed for each fracture outcome. The first model included adjustment for clinic site, age, BMI, prevalent fracture, bone medication use, self-reported health (i.e., excellent and good vs fair, poor, and very poor), physical activity score, RA status, and weight change since baseline. The second model included model 1 covariates and additionally adjusted for visit 3 TH BMD. The third model included model 1 covariates and additionally adjusted for annualized percent change in TH BMD from baseline to visit 3. The fourth model included model 1 covariates and both BMD and BMD change. Analogous models were used in exploratory analyses to estimate HRs and 95% CIs for hazards of specific types of fractures in men with thrombocytopenia vs men with normal platelet count, in men with low lymphocyte count vs men with normal lymphocyte count, and in men with high neutrophil count vs normal neutrophil count.
All P values reported were two sided, and all analyses were performed using SAS software version 9.4 (SAS Institute, Cary, NC).
Results
Participant characteristics at visit 3
Our analytic cohort consisted of 3632 men who had a median follow-up of 7.2 years after the third MrOS visit. Participant characteristics by anemia status are shown in Table 1 and by fracture event in Table 2 . Participants with anemia were slightly older, had lower BMI, were shorter, more often had RA, had more weight loss since baseline, were less active, less frequently reported excellent or good health, and had slightly lower total hip BMD. Among the 249 participants with anemia, Hgb level ranged from 8.1 to 11.9 g/dL with a median of 11.3 g/dL. Categorization of anemia by mean corpuscular volume revealed 10.4% microcytosis, 73.5% normocytosis, and 16.1% macrocytosis. Participants with any incident fracture were slightly older, had lower BMI, more often had a prevalent fracture, more often had RA, had slightly more weight loss since baseline, were less active, more often used bonepreserving medication, and had markedly lower TH BMD. Participants with incident fracture had weight change from baseline and self-reported health that was similar to those without fracture. Probability of fracture free follow-up Among the 3632 men in our analytic cohort, 562 had at least one new fracture. During the follow-up period, new nonspine and spine fractures developed in 498 and 92 participants, respectively. Kaplan-Meier curves depicting the proportion of participants who were free of specific fracture events are shown in Figure 1 . Participants with anemia were less likely to be free of any and nonspine fractures than those without (P , 0.0001 for both). There was no difference in probability of being free of spine fractures by anemia status.
Risk of specific fracture by anemia status
Cox proportional hazards models for specific fracture sites are presented in Table 3 . Anemia was associated with a 67% increased risk for any fracture (HR, 1.67; 95% CI, 1.26 to 2.21) and a 70% increased risk for nonspine fracture (HR, 1.70; 95% CI, 1.25 to 2.31) after adjustment for clinic site, age, BMI, prevalent fracture, bone medication use, self-reported health, physical activity score, RA status, and weight change since baseline. Every 1 standard deviation (SD) decrease in TH BMD was associated with a 52% increased risk of any fracture (HR, 1.52; 95% CI, 1.37 to 1.69) and with 61% increased risk of nonspine fracture (HR, 1.61; 95% CI, 1.44 to 1.81). In participants with anemia, the addition of TH BMD to our MV models (model 2) did not significantly alter the increased hazard of any fracture (HR, 1.68 vs 1.67) and nonspine fracture (HR, 1.72 vs 1.70). In separate MV-adjusted models, greater annualized BMD loss (per 1 SD of annualized BMD loss) at the TH was associated with a 22% hazard of any fracture (HR, 1.22; 95% CI, 1.12 to 1.33) and with a 32% increased hazard of nonspine fracture (HR, 1.32; 95% CI, 1.20 to 1.45). In participants with anemia, the addition of annualized BMD loss at the TH to our MV models (model 3) slightly attenuated the increased hazard of any fracture (HR, 1.60 vs 1.67) and nonspine fracture (HR, 1.57 vs 1.70). Similarly, MV models with additional adjustment of TH BMD at visit 3 and annualized BMD loss (model 4) did not significantly change the association between anemia and any fracture and nonspine fracture. Conversely, anemia was not associated with spine fracture in our study (HR, 1.39; 95% CI, 0.69 to 2.81). In addition, WBC subtype categories including high neutrophils and low lymphocytes and platelet counts were not associated with fractures in our study.
Discussion
We found that community-dwelling older men with anemia had a 57% to 72% increased risk of nonspine fractures during the mean 7.2 years of follow-up in MrOS, a prospective observational study. This risk was independent of prevalent fracture, BMD at the study starting point, and prior BMD loss. The magnitude of this increased risk is similar to that of established fracture risk factors included in FRAX (14) (15) (16) . To our knowledge, this is the largest evaluation of the effect of anemia on fractures in men and the only study that has taken into account repeated measures of BMD. Our findings suggest that a low Hgb level may be a biological marker of poor bone health and could be useful for fracture risk stratification. Alternatively, anemia itself may be predisposing bone to fracture, in which case it could also be evaluated as a target to reverse or ameliorate fracture risk in exposed individuals. The link between low Hgb level and bone health is becoming evident. We have previously found that BMD loss over time but not cross-sectional BMD is associated with anemia (8) . Others have shown that low Hgb level is associated with lower BMD by quantitative computed tomography, especially in cortical bone (9) . In women, anemia was observed to increase risk of hip fracture by 38% to 81% (6), and previous reports have also shown Values are given as HR (95% CI) for specific fracture.
Abbreviation: BM, base model. a Base model adjusted for clinic site, age, BMI, prevalent fracture, bone medication use, self-reported health, rheumatoid arthritis, PASE physical activity score, and change in weight. b Adjustment per 1 SD decrease of total hip BMD.
c Adjustment per 1 SD decrease of annualized percent BMD change at the total hip.
d Hgb level ,12 g/dL. Figure 1 . Probability of being fracture free by fracture type. Kaplan-Meier curves of the proportion of participants that are free of (a) "any fracture" event, (b) "nonspine fracture" event, and (c) "spine fracture" event by anemia status over a median of 7.2 years' follow-up.
increased risk of nonspine (17) and hip fracture (7) in men. The increased risk of fracture is independent of the association of low Hgb concentration and bone density. We found that BMD was associated with a 61% increase in risk of nonspine fracture, whereas previous BMD loss was associated with a 32% increase. These findings are consistent with the well-known associations of BMD and fracture (18) , where absolute BMD is a stronger predictor of fractures than change in BMD over time (19) (20) (21) . In the current study, we observed that, despite having a stronger association with fractures, adjusting for absolute BMD in our models had no effect on the increased risk of fracture in participants with anemia. Prior studies have found that the increased fracture risk in participants with anemia persisted after adjusting for forearm DXA (17) and categorical osteoporosis diagnosis (6) but did not specifically look at the contribution of these factors. Looker (7) found that femoral neck BMD attenuated the low Hgb level and hip fracture relationship but intensified the high Hgb level and hip fracture relationship, suggesting that Hgb and bone may interact differently across the range of Hgb values. When we adjusted for BMD loss, the increased risk of fracture was slightly attenuated. This indicates that BMD loss does not explain the entire anemia-fracture relationship. Anemia is also known to be associated with disability, decreased physical activity, and lower muscle strength (22) ; however, the increased fracture risk persisted regardless of adjustment for physical activity and poor self-reported health. Although it may be that muscle mass or strength is still residually confounding our results, there is likely an independent mechanism of bone fragility that is not captured by BMD measurements but is captured by Hgb measurement. Disorders of human red blood cell production such as thalassemia and sickle cell anemia are examples of clinically relevant bone phenotypes in disorders of hematopoiesis in humans. They are associated with increased risk of skeletal complications including fractures (23, 24) . In animal models, there is evidence that cells of the osteoblast lineage interact with hematopoietic cells (25) . Terminally differentiated osteoblasts and osteocytes influence myelopoiesis (26) , whereas B-lymphocyte and erythrocyte lineages depend on osteoblast progenitors (27) (28) (29) (30) (31) (32) . We did not find that WBC subtypes were associated with fractures (data not shown), which could mean that although bone loss is associated with high neutrophil and low lymphocyte counts (8) , these blood cell count patterns cannot be used to predict fractures.
We did not find an association between anemia and spine fractures in our study, in contrast to women in the Women's Health Initiative cohort (6) . In MrOS, vertebral fracture reports were adjudicated, whereas the Women's Health Initiative did not adjudicate nonhip fracture reports (6), which could account for the difference in our findings. The few other studies that have looked at anemia and fracture in men (7, 17) did not include spine fracture assessment and so do not help clarify this issue. It may be that men and women differ with respect to how anemia affects the spine. It is unclear why anemia increases the risk for nonspine fractures but not for spine fractures in men, although differences in marrow composition (33) or biomechanical properties (34) might contribute. There were only 92 spine fractures in this sample, so it is possible that this study lacked statistical power to detect a difference in spine fracture between participants with and without anemia.
Our study has several strengths and limitations. The analyses were performed in a large, prospective, observational cohort of community-dwelling older men. The cohort was multisite across the United States and was well characterized in detail, from extensive data collection using standardized questionnaires, interviews, examinations, DXA, blood samples, and assay methods. However, because of the primarily white and solely male cohort, generalizability to women and other racial or ethnic groups is unclear. Although there is interindividual variability in blood cell counts, the large sample size of the study population should minimize possible bias in our findings. We did not have information on the etiology of anemia, which could be important because iron/folate deficiency was shown to attenuate the increased risk of hip fracture in anemic patients in a previous study (7) . We do know that the participants had predominantly normocytic anemia, which is most often caused by chronic inflammation (35) . We did not have testosterone level at visit 3 for our participants, which could be a confounder for the effect of anemia on fracture risk. Similarly, a general health instrument; measurements of nutritional states such as albumin, vitamin D, and calcium; and bone turnover markers would have been useful to include in our models, but these were not available in MrOS at visit 3. We considered the potential interaction of renal function and anemia on BMD and fractures. Estimated glomerular filtration rate (eGFR) was estimated from blood tests at MrOS baseline but not 5 to 9 years later at visit 3. The estimates were not included in our models; however, of the men included in our analysis, 2.6% had an eGFR ,45 mL/min/1.73 m 2 and only 0.2% had a eGFR ,30 mL/min/1.73 m 2 at baseline. None of the men with eGFR ,30 mL/min/1.73 m 2 at baseline had anemia at visit 3. In prior studies, the low Hgb level and fracture association persisted despite controlling for eGFR ,30 mL/min/1.73 m 2 (7) and serum creatinine level (17) .
In summary, after controlling for multiple factors, we found that men with anemia had an increased risk for nonspine fractures. The mechanism of this relationship is unclear, but it appears that it is not mediated by bone density. A Hgb assessment may be helpful for fracture risk stratification.
